Childs popularity might predict good reading skills How are you first graders social abilities?

That is the finding from a report released in the January/February 2006 issue of the journal Child Development. The study, from experts from Stanford University, also finds the opposite – that kids with low reading abilities in 1st and third grade will have relatively high intense behavior in third and fifth grades. The researchers thought we would explore this issue in light to the fact that the social and educational realms in college are inextricably linked. ‘Children’s sociable behavior can promote or undermine their learning,’ explains lead author Sarah Miles, a Ph.D. Student at Stanford University, ‘and their academic efficiency may have implications for his or her social behavior.’ Although earlier studies show that social skills and academic accomplishment were linked, this scholarly study is the first to check out these relationships as time passes, examine both aggressive and prosocial behavior and focus on low-income kids who are particularly at risk for problems in school.Dr. Jorge Cortes, MD, Professor of Deputy and Medicine Chair in the Department of Leukemia at The University of Texas, MD Anderson Cancer Center will show data via oral presentations for both ChemGenex studies 202 and 203. Related StoriesProtein-coding gene identified as tumor suppressor for severe myeloid leukemiaPenn research forms basis for fresh treatment methods for Sezary syndromeDr. Paul Liu named 2015 Distinguished Alumnus for contributions to leukemia researchOn Monday, december at 4:45 p 7th.m. Central Time, Dr.m. Central Time. ChemGenex will also present combination data for Omapro through the poster program entitled: Chronic Myeloid Leukemia – Therapy on Sunday, 6th from 6:00 to 8:00 p December.m. Central Time on Poster Plank II-170.

Angiotensin system inhibitor use improves metastatic RCC survival outcomes By Shreeya Nanda, Senior medwireNews Reporter Usage of angiotensin program inhibitors is associated with significant survival benefits in metastatic renal cell carcinoma patients treated in the targeted therapy period, research findings indicate.